DARE (Dare Bioscience) FCF Margin %: -3,632.24% (As of Mar. 2026)


DARE Dare Bioscience Inc DARE
23 GF Score
Price $2.00
! 4 Warning Signs
View Full Analysis

What is Dare Bioscience FCF Margin %?

Dare Bioscience DARE -3.85% 23 FCF Margin % is -3,632.24% as of Mar. 2026. GuruFocus rates DARE with a GF Score™ of 23/100. The stock has 4 warning signs investors should review. Among 959 Biotechnology companies, Dare Bioscience ranks worse than 78% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Dare Bioscience's Free Cash Flow for the three months ended in Mar. 2026 was $-5.52 Mil. Dare Bioscience's Revenue for the three months ended in Mar. 2026 was $0.15 Mil. Therefore, Dare Bioscience's FCF Margin % for the quarter that ended in Mar. 2026 was -3,632.24%.

As of today, Dare Bioscience's current FCF Yield % is -33.93%.

The historical rank and industry rank for Dare Bioscience's FCF Margin % or its related term are showing as below:

DARE' s FCF Margin % Range Over the Past 10 Years
Min: -1406.2   Med: -589.35   Max: 49010
Current: -878.57

During the past 13 years, the highest FCF Margin % of Dare Bioscience was 49010.00%. The lowest was -1406.20%. And the median was -589.35%.

DARE's FCF Margin % is ranked worse than
78% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs DARE: -878.57

Dare Bioscience FCF Margin % Related Terms

Dare Bioscience FCF Margin % Historical Data

* Premium members only.

The historical data trend for Dare Bioscience's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dare Bioscience FCF Margin % Chart

Dare Bioscience Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -181.51 -1,406.20 49,010.00 -997.18

Dare Bioscience Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22,512.00 25,066.67 -30,850.00 120.80 -3,632.24

DARE vs TVGN, LITS, BOLD: FCF Margin % Comparison

For the Biotechnology subindustry, Dare Bioscience's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dare Bioscience FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dare Bioscience's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Dare Bioscience's FCF Margin % falls into.


DARE
23GF Score
Dare Bioscience Inc DARE
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dare Bioscience FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Dare Bioscience's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-10.271/1.03
=-997.18 %

Dare Bioscience's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-5.521/0.152
=-3,632.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -3,632.24% mean?
Dare Bioscience (DARE) has a FCF Margin % of -3,632.24% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Dare Bioscience and its competitors. According to the industry distribution chart, Dare Bioscience ranks #748 out of 959 companies in the Biotechnology industry, placing it in the top 78%.
Is Dare Bioscience's FCF Margin % too high?
Dare Bioscience's current FCF Margin % is -3,632.24%. Based on the distribution chart, Dare Bioscience ranks #748 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Dare Bioscience has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Dare Bioscience's FCF Margin % compare to TVGN and LITS?
According to the Biotechnology industry distribution chart, Dare Bioscience ranks #748 out of 959 companies for FCF Margin %. This places Dare Bioscience in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Dare Bioscience and its competitors. Dare Bioscience's current FCF Margin % is -3,632.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dare Bioscience stock overvalued right now?
Dare Bioscience (DARE) has a current FCF Margin % of -3,632.24%. The current FCF Margin % is -3,632.24%. Dare Bioscience's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Dare Bioscience (DARE), the current FCF Margin % is -3,632.24% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dare Bioscience Business Description

Address 3655 Nobel Drive, Suite 260, San Diego, CA, USA, 92122
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
23GF Score

Get the complete analysis for DARE

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.00
Price